Director, Regulatory Affaira - Director, Regulatory Affairs bei Merck: Mitarbeiterbewertung

3,0
27. Apr. 2018
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great scientific environment to work in with folks who are committed to doing cutting edge research and getting medicines to patients who need them!

Kontras

Frequent reporting structure changes means changing projects often which is extremely disruptive to individual programs and teams. This is the first company I’ve worked for where your project is strictly tied to who your boss is.

Mehr Bewertungen zu Merck entdecken

5,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Excellent company to work with.

Kontras

No cons encountered so far

4,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Kontras

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle